NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
Journal of the National Comprehensive Cancer Network · 2023-04 · 21 (4) · 340-350
DOI: 10.6004/jnccn.2023.0020 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023-04. Verfasst von David S Ettinger und 42 weiteren Autor:innen. Beteiligte Einrichtung: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 489-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus on neoadjuvant and adjuvant (also known as perioperative) systemic therapy options for eligible patients with resectable NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Fred Hutchinson Cancer Center.
- University of Colorado Cancer Center.
- Huntsman Cancer Institute at the University of Utah.
- Fox Chase Cancer Center.
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Zitieren
APA
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., DeCamp, M., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Hegde, A., Lackner, R. P., Lanuti, M., …, & Hughes, M. (2023). NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023. Journal of the National Comprehensive Cancer Network, 21(4), 340-350. https://doi.org/10.6004/jnccn.2023.0020
Vancouver
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023. Journal of the National Comprehensive Cancer Network. 2023;21(4):340-350. doi:10.6004/jnccn.2023.0020
BibTeX
@article{Ettinger2023,
author = {Ettinger, David S and Wood, Douglas E and Aisner, Dara L and Akerley, Wallace and Bauman, Jessica R and Bharat, Ankit and Bruno, Debora S and Chang, Joe Y and Chirieac, Lucian R and DeCamp, Malcolm and Dilling, Thomas J and Dowell, Jonathan and Durm, Gregory A and Gettinger, Scott and Grotz, Travis E and Gubens, Matthew A and Hegde, Aparna and Lackner, Rudy P and Lanuti, Michael and Lin, Jules and Loo, Billy W and Lovly, Christine M and Maldonado, Fabien and Massarelli, Erminia and Morgensztern, Daniel and Ng, Thomas and Otterson, Gregory A and Patel, Sandip P and Patil, Tejas and Polanco, Patricio M and Riely, Gregory J and Riess, Jonathan and Schild, Steven E and Shapiro, Theresa A and Singh, Aditi P and Stevenson, James and Tam, Alda and Tanvetyanon, Tawee and Yanagawa, Jane and Yang, Stephen C and Yau, Edwin and Gregory, Kristina M and Hughes, Miranda},
title = {NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2023},
volume = {21},
number = {4},
pages = {340--350},
doi = {10.6004/jnccn.2023.0020}
}
EUVIMED